课题基金 / 基金详情

Induction of programmed death of tumor cells by activation of betal integrin.

Induction of programmed death of tumor cells by activation of betal integrin.
通过激活β整合素诱导肿瘤细胞程序性死亡。
批准号:
17590074
负责人:
FUKAI Fumio
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

FUKAI Fumio的其他基金

相似基金

相关文献

中文摘要
翻译
研究TNIII通过刺激β1整合素活化诱导肿瘤细胞程序性死亡的分子机制。tniii诱导的β 1整合素激活诱导FAK (Tyr397)、FAK (Tyr 925)、Src (Tyr397)和Akt的去磷酸化,导致WI38VA13纤维肉瘤样细胞发生caspase非依赖性凋亡死亡。这种细胞凋亡伴随着AIF的核易位,已知与caspase非依赖性细胞凋亡有关。此外,TNIII刺激Rac活化和随后产生活性氧香料(ROS),提示ROS参与了TNIII诱导的凋亡细胞死亡。有趣的是,tniii诱导的正常成纤维细胞的反应与肿瘤细胞的反应明显不同。TNIII完全拯救了正常成纤维细胞NIH3T3免于血清剥夺的凋亡,其中Ras处于静息状态被激活。与之形成鲜明对比的是,TNIII诱导了纤维肉瘤样WI38VA13细胞的凋亡死亡,其中处于组成性活性状态的Ras短暂失活。为了解释细胞对TNIII反应的差异,构建了稳定表达Ras组成型活性突变体(NIH-V7)的NIH3T3细胞。当NIH-V7细胞与TNIII孵育时,细胞发生程序性死亡,并伴有Ras的短暂失活。因此,TNIII似乎具有通过刺激Ras激活来控制细胞存活/凋亡的能力,其中Ras的激活状态可能是细胞存活或凋亡的重要决定因素。
英文摘要
Molecular mechanism by which TNIII induces programmed death of tumor cells through stimulating β1 integrin activation was investigated. TNIII-induced activation of βl integrins induced dephosphorylation of FAK (Tyr397), FAK (Tyr 925), Src (Tyr 397) and Akt, resulting in caspase-independent apoptotic death of WI38VA13 fibrosarcoma-like cells. This apoptosis was accompanied by the nuclear translocation of AIF that is known to be implicated in caspase-independent apoptosis. Additionally, TNIII stimulated Rac activation and subsequent generation of reactive oxygen spices (ROS), suggesting the involvement of ROS in the TNIII-induced apoptotic cell death.Interestingly, TNIII-induced response of normal fibroblasts was clearly distinct from that of tumor cells. TNIII completely rescued mormal fibroblasts NIH3T3 from the serum-deprived apoptosis, in which Ras in a resting state was activated. In sharp contrast, TNIII elicited apoptotic death against fibrosarcoma-like WI38VA13 cells, in which Ras in a constitutively active state was transiently inactivated. To explain this difference in cellular response to TNIII, NIH3T3 cells stably expressing constitutively active mutant of Ras (NIH-V7) were constructed. When NIH-V7 cells were incubated with TNIII, the cells underwent programmed death in concomitant with a transient inactivation of Ras.Thus, TNIII appears to have the ability to control cell survival/apoptosis by stimulating Ras activation, in which the activation status of Ras may be an important determinant whether cells survive or undergo apoptosis.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
抗がん剤
抗癌剂
DOI: --
发表时间: 2019
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.2183/pjab.82.181
发表时间: 2006-05-01
期刊: PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
影响因子: 3.1
作者: [Asakawa, Hideo, Sasabe, Masataka, Takasaki, Seiichi]
通讯作者: Takasaki, Seiichi
Molecular mechanism for malignant cell transformationinduced by a peptide derived from tenascin C through integrin activation
  • 批准号:
    23590090
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.58万
  • 财政年份:
    2011
  • 负责人:
    FUKAI Fumio
  • 依托单位:
Identification of a membrane receptor mediating the biological effects of the fibronectin-derivedantiadhesive peptide FNIII 14.
  • 批准号:
    11680615
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $0.64万
  • 财政年份:
    1999
  • 负责人:
    FUKAI Fumio
  • 依托单位:
Adipocyte differentiation of ST-13 cells induced by fibronectin fragment
Molecular mechanism of fibronectin-induced chemotactic migration
国内基金
海外基金
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
  • 批准号:
    82300764
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    郑茜子
  • 依托单位:
Tenascin-C促进巨噬细胞向肌成纤维细胞转化在肾脏纤维化中的作用机制研究
  • 批准号:
    82300792
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    田媛
  • 依托单位:
Tenascin R在阿尔茨海默病发生发展中的作用和机制研究
RET-M918T突变通过调控Tenascin C-EGFR复合体形成促进甲状腺髓样癌干性和侵袭转移的机制研究
  • 批准号:
    82373008
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    史潇
  • 依托单位: